Seffalair Spiromax

fluticasone propionate; salmeterol xinafoate · Teva B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Seffalair Spiromax, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: EMA Authorised: Seffalair Spiromax (fluticasone propionate;salmeterol xinafoate) — Teva B.V.